Article

OptiMedica unveils new photocoagulator at WOC

OptiMedica Corp. announced the debut of its new photocoagulator (PASCAL Slim Line) here at the World Ophthalmology Congress. The system provides physicians and their patients with the significant benefits of pattern-scanning in a new, compact design.

OptiMedica Corp. announced the debut of its new photocoagulator (PASCAL Slim Line) here at the World Ophthalmology Congress.The system provides physicians and their patients with the significant benefits of pattern-scanning in a new, compactdesign.

Representing a leap forward from single-spot green laser photocoagulation, the company's proprietary, semi-automated patterngeneration allows for the rapid delivery of 532 nm laser pulses in a predetermined sequence. Indicated for a variety ofretinal diseases-including diabetic retinopathy, age-related macular degeneration, and retinal vascular occlusivedisease-the technique enables physicians to improve their control of the precision, safety, and efficiency of thephotocoagulation procedure, while optimizing patient comfort and convenience, according to OptiMedica.

"The launch of the [photocoagulator] represents OptiMedica's unwavering commitment to meeting customer needs," said Mark J.Forchette, president and chief executive officer of OptiMedica. "We are thrilled to report that early users have alreadygiven us rave reviews for [its] performance and sleek design, which together are aimed at addressing the unique clinical andeconomic challenges of the office-based practice."

The new photocoagulator is currently available in the United States and Japan and will be rolled out worldwide over thefourth quarter of 2008.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.